Exagen logo

Exagen

XGN | NASDAQ
Chart Builder DCF Calculator
$3.77
-$0.36 (-8.72%)
At close: Nov 16, 2026, 4:00 PM ET
$3.80
+$0.03 (+0.80%)
After-hours: Nov 16, 2026, 7:30 PM ET
-8.72%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
36.8
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #622/1021 (Top 61%)

Key Statistics

Market Data

Market Cap $96.19M
1D Range
3.75 4.12
52W Range
2.65 8.74

Valuation (TTM)

PE -4.96
PB 6.98
EV/EBITDA -8.57

Valuation (NTM)

Forward PE N/A
Forward PEG 0.30
Price Target $9.50
Loading financial charts...

Profile

Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the Uni...

Sector Healthcare
Employees 216
IPO Date Sep 19, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.25
Miss -37.29%
REV
$18.42M
Beat +0.42%
Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$9.50
Upside
+151.99%
Buy (6)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.